You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 396 NT-I7, a long-acting interleukin-7, promotes expansion of CD8 T cells and NK cells and immune activation in patients with newly diagnosed high-grade gliomas after chemoradiation

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
396 NT-I7, a long-acting interleukin-7, promotes expansion of CD8 T cells and NK cells and immune activation in patients with newly diagnosed high-grade gliomas after chemoradiation
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

AbstractFullPdf
Nov 2021426035
Dec 20219408
Jan 202274013
Feb 202211207
Mar 2022300022
Apr 2022132014
May 202270017
Jun 202296011
Jul 202296021
Aug 202288012
Sep 202258012
Oct 202254016
Nov 2022100014
Dec 20224403
Jan 20234403
Feb 202342010
Mar 20233201
Apr 20232006
May 20232602
Jun 20232603
Jul 20231809
Aug 20231809
Sep 20235207
Oct 202348011
Nov 20235806
Dec 20234806
Jan 20249606
Feb 20246001
Mar 202430035
Total23620320